Literature DB >> 1742877

Iodine-131 treatment of hyperthyroidism: current issues.

J J Farrar1, A D Toft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1742877     DOI： 10.1111/j.1365-2265.1991.tb03523.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  10 in total

Review 1.  Diagnosis and management of Graves' disease.

Authors:  Jody Ginsberg
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

Review 2.  The role of surgery in primary hyperthyroidism.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

3.  Outcome of treatment of hyperthyroidism.

Authors:  I M Bringmann; B L van Leeuwen; G Hennemann; G J Beckett; A D Toft
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

4.  Radioiodine treatment of multinodular non-toxic goitre.

Authors:  B Nygaard; L Hegedüs; M Gervil; H Hjalgrim; P Søe-Jensen; J M Hansen
Journal:  BMJ       Date:  1993-10-02

Review 5.  Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?

Authors:  A P Weetman; B J Harrison
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

6.  Radiometabolic treatment of hyperthyroidism with a calculated dose of 131-iodine: results of one-year follow-up.

Authors:  C Regalbuto; I Marturano; A Condorelli; A Latina; V Pezzino
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

7.  Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.

Authors:  Cihangir Erem; Nurten Kandemir; Arif Hacihasanoglu; Halil Onder Ersöz; Kubilay Ukinc; Mustafa Kocak
Journal:  Endocrine       Date:  2004-10       Impact factor: 3.633

8.  Thyroid volume's influence on energy deposition from (131)I calculated by Monte Carlo (MC) simulation.

Authors:  Ali Asghar Mowlavi; Maria Rosa Fornasier; Mario de Denaro
Journal:  Radiol Oncol       Date:  2011-03-29       Impact factor: 2.991

9.  Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.

Authors:  Anthony Lewis; Brew Atkinson; Patrick Bell; Hamish Courtney; David McCance; Karen Mullan; Stephen Hunter
Journal:  Ulster Med J       Date:  2013-05

10.  Dosimetry-based treatment for Graves' disease.

Authors:  Steve L Hyer; Brenda Pratt; Matthew Gray; Sarah Chittenden; Yong Du; Clive L Harmer; Glenn D Flux
Journal:  Nucl Med Commun       Date:  2018-06       Impact factor: 1.690
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.